Alexion founder Bell to retire as CEO

Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) said principal founder Leonard Bell will retire as CEO, effective April 1, while remaining chairman.

COO David Hallal, who joined

Read the full 242 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE